Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014334953> ?p ?o ?g. }
- W2014334953 endingPage "149" @default.
- W2014334953 startingPage "135" @default.
- W2014334953 abstract "Negative regulation of osteoclastogenesis is important for bone homeostasis and prevention of excessive bone resorption in inflammatory and other diseases. Mechanisms that directly suppress osteoclastogenesis are not well understood. In this study we investigated regulation of osteoclast differentiation by the β2 integrin CD11b/CD18 that is expressed on myeloid lineage osteoclast precursors. CD11b-deficient mice exhibited decreased bone mass that was associated with increased osteoclast numbers and decreased bone formation. Accordingly, CD11b and β2 integrin signaling suppressed osteoclast differentiation by preventing receptor activator of NF-κB ligand (RANKL)-induced induction of the master regulator of osteoclastogenesis nuclear factor of activated T cells, cytoplasmic 1 (NFATc1) and of downstream osteoclast-related NFATc1 target genes. CD11b suppressed induction of NFATc1 by the complementary mechanisms of downregulation of RANK expression and induction of recruitment of the transcriptional repressor B-cell lymphoma 6 (BCL6) to the NFATC1 gene. These findings identify CD11b as a negative regulator of the earliest stages of osteoclast differentiation, and provide an inducible mechanism by which environmental cues suppress osteoclastogenesis by activating a transcriptional repressor that makes genes refractory to osteoclastogenic signaling." @default.
- W2014334953 created "2016-06-24" @default.
- W2014334953 creator A5002442504 @default.
- W2014334953 creator A5017917813 @default.
- W2014334953 creator A5019770989 @default.
- W2014334953 creator A5034755041 @default.
- W2014334953 creator A5048328526 @default.
- W2014334953 creator A5064191889 @default.
- W2014334953 creator A5080984126 @default.
- W2014334953 creator A5084262507 @default.
- W2014334953 creator A5084611630 @default.
- W2014334953 creator A5087516945 @default.
- W2014334953 creator A5088803041 @default.
- W2014334953 date "2012-12-18" @default.
- W2014334953 modified "2023-10-05" @default.
- W2014334953 title "Negative regulation of osteoclast precursor differentiation by CD11b and<b>β</b>2 integrin-B-cell lymphoma 6 signaling" @default.
- W2014334953 cites W100698361 @default.
- W2014334953 cites W1489825629 @default.
- W2014334953 cites W1504092903 @default.
- W2014334953 cites W1838439206 @default.
- W2014334953 cites W1975154430 @default.
- W2014334953 cites W1976732545 @default.
- W2014334953 cites W1986580482 @default.
- W2014334953 cites W1987644069 @default.
- W2014334953 cites W1994517874 @default.
- W2014334953 cites W1996403236 @default.
- W2014334953 cites W1997585969 @default.
- W2014334953 cites W1997966580 @default.
- W2014334953 cites W1998369476 @default.
- W2014334953 cites W2004644593 @default.
- W2014334953 cites W2005020306 @default.
- W2014334953 cites W2015784912 @default.
- W2014334953 cites W2016209020 @default.
- W2014334953 cites W2017372504 @default.
- W2014334953 cites W2017530514 @default.
- W2014334953 cites W2028805384 @default.
- W2014334953 cites W2038476365 @default.
- W2014334953 cites W2046563117 @default.
- W2014334953 cites W2051152074 @default.
- W2014334953 cites W2056738560 @default.
- W2014334953 cites W2064346787 @default.
- W2014334953 cites W2064603645 @default.
- W2014334953 cites W2066749771 @default.
- W2014334953 cites W2078888308 @default.
- W2014334953 cites W2084423382 @default.
- W2014334953 cites W2086128996 @default.
- W2014334953 cites W2087378917 @default.
- W2014334953 cites W2090659127 @default.
- W2014334953 cites W2090795226 @default.
- W2014334953 cites W2091326509 @default.
- W2014334953 cites W2094539147 @default.
- W2014334953 cites W2099989406 @default.
- W2014334953 cites W2104713336 @default.
- W2014334953 cites W2114119367 @default.
- W2014334953 cites W2119049249 @default.
- W2014334953 cites W2119636762 @default.
- W2014334953 cites W2123993322 @default.
- W2014334953 cites W2125284377 @default.
- W2014334953 cites W2126238352 @default.
- W2014334953 cites W2131980428 @default.
- W2014334953 cites W2132408993 @default.
- W2014334953 cites W2132472913 @default.
- W2014334953 cites W2133511919 @default.
- W2014334953 cites W2134397552 @default.
- W2014334953 cites W2141089307 @default.
- W2014334953 cites W2142424019 @default.
- W2014334953 cites W2146565196 @default.
- W2014334953 cites W2149827038 @default.
- W2014334953 cites W2158300352 @default.
- W2014334953 cites W2158782513 @default.
- W2014334953 cites W2164423257 @default.
- W2014334953 cites W2168525870 @default.
- W2014334953 cites W2169458206 @default.
- W2014334953 cites W4242538620 @default.
- W2014334953 doi "https://doi.org/10.1002/jbmr.1739" @default.
- W2014334953 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3522783" @default.
- W2014334953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22893614" @default.
- W2014334953 hasPublicationYear "2012" @default.
- W2014334953 type Work @default.
- W2014334953 sameAs 2014334953 @default.
- W2014334953 citedByCount "48" @default.
- W2014334953 countsByYear W20143349532012 @default.
- W2014334953 countsByYear W20143349532013 @default.
- W2014334953 countsByYear W20143349532014 @default.
- W2014334953 countsByYear W20143349532015 @default.
- W2014334953 countsByYear W20143349532016 @default.
- W2014334953 countsByYear W20143349532017 @default.
- W2014334953 countsByYear W20143349532018 @default.
- W2014334953 countsByYear W20143349532019 @default.
- W2014334953 countsByYear W20143349532020 @default.
- W2014334953 countsByYear W20143349532021 @default.
- W2014334953 countsByYear W20143349532022 @default.
- W2014334953 countsByYear W20143349532023 @default.
- W2014334953 crossrefType "journal-article" @default.
- W2014334953 hasAuthorship W2014334953A5002442504 @default.
- W2014334953 hasAuthorship W2014334953A5017917813 @default.
- W2014334953 hasAuthorship W2014334953A5019770989 @default.
- W2014334953 hasAuthorship W2014334953A5034755041 @default.